Sign in
8-K

Current Report

Outlook Therapeutics, Inc. Filed Acc 0001558370-25-003013

Agreement ended · Bylaws or fiscal year change · Shareholder vote results

  • Item 1.02 Termination of a material definitive agreement
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading otlk-20250311x8k.htm…